(A) Distribution of studies, (B) episode-free days and (C) albuterol inhalations during the study run-in periods (mean ± SEM), and (D) prior year healthcare utilization for wheezing or asthma symptoms in all participants (N=1708) and each latent class (1 = minimal sensitization [N=494], 2 = sensitization with indoor pets [N=409], 3 = sensitization with tobacco smoke exposure [N=452], 4 = multiple sensitization with eczema [N=353]).